Physical InactivityNCT04743856
The Clinical Referral to Activity Study
A study testing ActiveGOALSv2 and PAT in people with Physical Inactivity and Cardiovascular Risk Factor, run by University of Pittsburgh at 1 site in United States.
Trial summary
The main aim of this effort is to test a physical activity intervention, for adult clinical care patients at risk of developing cardiovascular disease. The intervention includes social-cognitive theory-based sessions, remote coaching, a body worn physical activity tracker (PAT), and is delivered online over one year. Read more about this study
- Who is it for?
- Ages 40 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Physical Inactivity, Cardiovascular Risk Factor, Obesity
- What is being tested?
- ActiveGOALSv2 and PAT
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 54 participants
- Where
- 1 siteUnited States
- Study dates
- 29 Mar 2022to 10 Dec 2024
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age 40-70 years of age
- Low physical activity (PA) levels (<150 minutes/week)
- At least one of the following common cardiometabolic risk factors:
- high blood pressure:> 129 mm hg SP or >89 mm hg DP or medication
- high fasting glucose:>100 mg/dl or high HbA1c: ≥42 mmols/mol or medication
- overweight/ obesity: BMI ≥25 kg/m2).
Show all 9Show fewer
- Have access to the internet
- Able to read English at a 6th grade level
- Have primary care provider (PCP) permission to increase physical activity without supervision.
Who cannot join
- Have participated in a physical activity intervention program with behavior tracking and goal setting in the past year.
- Told by a physician that they have diabetes (other than previous gestational diabetes) or have received a diagnosis of cardiovascular disease, regardless of when.
- Pregnant or planning a pregnancy in <12 months
- Non-ambulatory or planning a procedure that will lead to not being ambulatory in <12 months.
- Women who become pregnant during the study will be required to get an updated referral form from their primary care provider (PCP) stating that they are able to increase their physical activity without supervision .
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Pittsburgh
Pittsburgh, Pennsylvania, 15261
About this study
Official title: Advancement of Clinical Referral to Physical Activity for Cardiometabolic Disease Prevention
The main aim of this effort is to test a physical activity intervention, for adult clinical care patients at risk of developing cardiovascular disease. The intervention includes social-cognitive theory-based sessions, remote coaching, a body worn physical activity tracker (PAT), and is delivered online over one year. The investigators hypothesis that this intervention will be more successful at increasing physical activity (defined as objectively measured step counts and % of individuals meeting the moderate-vigorous physical activity goal) as an active control group who receives a body worn PAT and information on the CDC activity recommendations. The proposed intervention will be aligned with efforts by the US Centers for Disease Control to increase population physical activity levels and the American College of Sports Medicine (ACSM) to increase physical activity prescription in primary care.
Read the detailed description
The main aim of this effort is to test a physical activity intervention, for adult clinical care patients at risk of developing cardiovascular disease. The intervention includes 13 weekly and 6 monthly social-cognitive theory-based sessions, remote coaching, a body worn physical activity tracker (PAT), and is delivered online over one year.
A total of n=54 Clinical care patients aged 40-70 years of age with low physical activity (PA) levels (<150 minutes/week) at risk for cardiovascular disease will be recruited. Study outcomes will be measured at baseline, 6 months after intervention start and 12 months after intervention start.
For the primary outcomes, the investigators hypothesize that participants randomized to ActiveGOALSv2 + PAT will have significantly larger (a) increases in step counts/day and % meeting moderate-vigorous physical activity goal of 150 minutes/week (to 12 months) compared to the active PAT control group. Descriptive analyses and graphic displays will be used to identify outliers, missing data, and pattern of attrition. To ensure rigor, the primary analytic strategy will be a linear or generalized mixed-effect models approach in which treatment group, time, and time by group interaction are treated as fixed effects, and subject is treated as a random effect to account for individual subject variability (two sided hypothesis test; .05 level). Mixed models are applicable to longitudinal datasets that contain missing observations, (assuming data is missing at random). Regression modeling will be conducted to adjust for important covariates. The investigators will perform similar analyses to examine changes in secondary outcomes. Descriptive statistics on patient experience, beliefs/attitudes related to maintenance of physical activity changes, and program cost will also be reported.
Power and sample size: For a 2 sided test with alpha level set at .05, and assuming 20% attrition at 12 months, the investigators plan to recruit 54 participants to identify clinically relevant mean difference between randomized groups at 12-months of 2000 steps/day (with a power of .80), and 35% meeting MVPA goal (with a power of .80), given reference mean (sd) values were calculated from baseline waist worn accelerometer data from the current K12 of: 5250 (2200) steps/ day and the investigators assume 5% meeting goal at baseline in the control group.
Descriptive statistics will be used to describe the total eligible population, those referred, and those referred who participated in the study; in order to determine program reach. Exploratory Analysis of Important Pre-Existing Factors: Factor analysis will be used to identify importance of factors related to physical activity levels/ activity goal achievement over the 12 month follow-up (Mplus) from participant EHR data collected prior to intervention start. Factor structures of how individual factors contribute to activity outcomes will be explored at each time point. The best factor structure will be determined with Eigenvalues and fit indices (RMSEA, CFI, and TLI). Factor structures at the 2 time points will be compared at three levels to establish measurement invariance: 1) Configural equivalence, number of factors/ pattern of factor-indicator relationships are identical over time; 2) Metric equivalence, factor loadings are equal over time; and 3) Scalar equivalence, means and values are equivalent over time. Finally, the investigators will use descriptive statistics to report presence/absence of data on physical activity levels, cardiometabolic, and patient-centered outcomes in the EHR. The investigators will apply the same regression approaches utilized in Aim 1a to determine differences between randomized groups for EHR reported outcomes.
- Being tested
- ActiveGOALSv2, PAT
- Keywords
- Physical activity, Online lifestyle Intervention, Cardiovascular disease, Disease prevention
- Medical subject headings
- Sedentary Behavior, Obesity, Prediabetic State, Motor Activity, Cardiovascular Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ActiveGOALSv2Behavioural
13 weekly self-guided sessions on problem solving and goal setting related to increasing physical activity, and weekly remote coaching support. Once a month support materials sent monthly from months 4-12 of intervention.
PATBehavioural
Participants will receive a physical activity tracker and encouragement to increase activity.
| Study group | Role | What they receive |
|---|---|---|
| PAT (Physical activity monitor) | Active comparator | Participants will receive a physical activity tracker and encouragement to increase physical activity. Receives: Behavioral: PAT |
| ActiveGOALSv2 | Experimental | Participants will receive the ActiveGOALS online program with an integrated activity tracker. Receives: Behavioral: ActiveGOALSv2 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change From Baseline in Meeting the Aerobic Activity Goal at 12 Months
Change between 0 and 12 months for y/n meeting the 150 minute/week moderate-vigorous activity goal based on minutes of activity from accelerometer
Measured: 12 months versus baseline
Change From Baseline in Step Counts at 12 Months
Objectively measured change in step counts between 0 and 12 months using ActiGraph accelerometer
Measured: 12 months versus baseline
Secondary outcomes (15)
Sedentary Behavior Minutes Over All Timepoints for 12 Months
Objectively measured sedentary behavior at each timepoint using ActiGraph accelerometer worn for 1 week, data for a given timepoint was averaged using only valid days during that week to assess average minutes/day. Valid days are days the monitor was worn for 10 or more hours.
Measured: baseline, 6 and 12 months
Moderate-vigorous Activity Minutes Over All Timepoints for 12 Months
Objectively measured moderate-vigorous activity at each timepoint using ActiGraph accelerometer worn for 1 week, data for a given timepoint was averaged using only valid days during that week to assess average minutes/day. Valid days are days the monitor was worn for 10 or more hours.
Measured: baseline, 6 and 12 months
Light Activity Minutes Over All Timepoints for 12 Months
Objectively measured Light activity at each timepoint using ActiGraph accelerometer worn for 1 week, data for a given timepoint was averaged using only valid days during that week to assess average minutes/day. Valid days are days the monitor was worn for 10 or more hours.
Measured: baseline, 6 and 12 months
Step Counts Over All Timepoints for 12 Months
Objectively measured Step counts at each timepoint using ActiGraph accelerometer worn for 1 week, data for a given timepoint was averaged using only valid days during that week to assess average steps/day. Valid days are days the monitor was worn for 10 or more hours.
Measured: baseline, 6 and 12 months
Patient Experience
patient experience survey designed for this study with the help of patient partners to gather feedback from participants. Feedback will be used in the development of future interventions
Measured: measured at 6 and 12 months
Systolic Blood Pressure Over All Timepoints for 12 Months
Taken by trained clinic staff using a validated automated blood pressure cuff after participant is seated in an upright position for 5 minutes. Two measure will be taken and the average of the two measures will be used. If the measures are not within 5 mmHG, a third measure will be taken.
Measured: measured at baseline, 6 and 12 months
Body Weight Over All Timepoints for 12 Months
will be measured in clinic by trained staff using a validated scale. Participants will be asked to take shoes off and wear light clothes. Average of two measures will be used; if weight is more than .5 pounds different, a third will be taken.
Measured: measured at baseline, 6 and 12 months
Waist Circumference Over All Timepoints for 12 Months
will be measured above the iliac crest in clinic by trained staff. Two measures will be taken and averaged; if measures are more than 1 cm different a third measure will be taken.
Measured: measured at baseline, 6 and 12 months
Fasting Blood Glucose Over All Timepoints for 12 Months
A fasting blood draw will be taken after 12-16 hours fast.
Measured: measured at baseline, 6 and 12 months
HbA1c Over All Timepoints for 12 Months
A fasting blood draw will be taken after 12-16 hours fast.
Measured: measured at baseline, 6 and 12 months
LDL Cholesterol Over All Timepoints for 12 Months
A fasting blood draw will be taken after 12-16 hours fast.
Measured: measured at baseline, 6 and 12 months
HDL Cholesterol Over All Timepoints for 12 Months
A fasting blood draw will be taken after 12-16 hours fast.
Measured: measured at baseline, 6 and 12 months
Perceived Health Score Over All Timepoints for 12 Months
EuroQAL Visual Analogue Scale (EQ-VAS)-Self-reported perception of health on a 0 (lowest possible) to 100 (highest possible) scale.
Measured: measured at baseline, 6 and 12 months
Insulin Over All Timepoints for 12 Months
A fasting blood draw will be taken after 12-16 hours fast.
Measured: measured at baseline, 6 and 12 months
Triglycerides Over All Timepoints for 12 Months
A fasting blood draw will be taken after 12-16 hours fast.
Measured: measured at baseline, 6 and 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Feb 2021
- Study start29 Mar 2022
- Primary completion30 Sep 2024
- Study completion10 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Physical InactivityStudies of the same condition, open and under way.
- More trials run by University of PittsburghThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomized 1:1 to one of two intervention conditions.
- Masking
- Double blind
- Who is masked
- Care provider, Outcomes assessor
- Enrolment
- 54 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Pittsburgh
- Sponsor type
- University, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Responsible party
- Principal investigator, Bonny Rockette-Wagner, University of Pittsburgh
- Investigators
- Bonny Rockette-Wagner, PhD, Principal investigator, University of Pittsburgh
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04743856
- Sponsor's protocol ID
- STUDY20030079
- Other IDs
- 1K01HL151668-01
- Status last verified
- Apr 2026
- First submitted
- 10 Jan 2021
- Last updated
- 12 May 2026
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Advancement of Clinical Referral to Physical Activity for Cardiometabolic Disease Prevention
- ClinicalTrials.gov ID
- NCT04743856
- Acronym / sponsor ID
- STUDY20030079
- Keywords
- Physical activity, Online lifestyle Intervention, Cardiovascular disease, Disease prevention
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 54 participants (actual)
- Lead sponsor
- University of PittsburghUniversity, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Study start
- 29 Mar 2022 (actual)
- Primary completion
- 30 Sep 2024 (actual)
- Study completion
- 10 Dec 2024 (actual)
- First posted
- 8 Feb 2021 (actual)
- Results
- Posted 19 Nov 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main aim of this effort is to test a physical activity intervention, for adult clinical care patients at risk of developing cardiovascular disease. The intervention includes social-cognitive theory-based sessions, remote coaching, a body worn physical activity tracker (PAT), and is delivered online over one year. The investigators hypothesis that this intervention will be more successful at increasing physical activity (defined as objectively measured step counts and % of individuals meeting the moderate-vigorous physical activity goal) as an active control group who receives a body worn PAT and information on the CDC activity recommendations. The proposed intervention will be aligned with efforts by the US Centers for Disease Control to increase population physical activity levels and the American College of Sports Medicine (ACSM) to increase physical activity prescription in primary care.
Detailed description
The main aim of this effort is to test a physical activity intervention, for adult clinical care patients at risk of developing cardiovascular disease. The intervention includes 13 weekly and 6 monthly social-cognitive theory-based sessions, remote coaching, a body worn physical activity tracker (PAT), and is delivered online over one year.
A total of n=54 Clinical care patients aged 40-70 years of age with low physical activity (PA) levels (<150 minutes/week) at risk for cardiovascular disease will be recruited. Study outcomes will be measured at baseline, 6 months after intervention start and 12 months after intervention start.
For the primary outcomes, the investigators hypothesize that participants randomized to ActiveGOALSv2 + PAT will have significantly larger (a) increases in step counts/day and % meeting moderate-vigorous physical activity goal of 150 minutes/week (to 12 months) compared to the active PAT control group. Descriptive analyses and graphic displays will be used to identify outliers, missing data, and pattern of attrition. To ensure rigor, the primary analytic strategy will be a linear or generalized mixed-effect models approach in which treatment group, time, and time by group interaction are treated as fixed effects, and subject is treated as a random effect to account for individual subject variability (two sided hypothesis test; .05 level). Mixed models are applicable to longitudinal datasets that contain missing observations, (assuming data is missing at random). Regression modeling will be conducted to adjust for important covariates. The investigators will perform similar analyses to examine changes in secondary outcomes. Descriptive statistics on patient experience, beliefs/attitudes related to maintenance of physical activity changes, and program cost will also be reported.
Power and sample size: For a 2 sided test with alpha level set at .05, and assuming 20% attrition at 12 months, the investigators plan to recruit 54 participants to identify clinically relevant mean difference between randomized groups at 12-months of 2000 steps/day (with a power of .80), and 35% meeting MVPA goal (with a power of .80), given reference mean (sd) values were calculated from baseline waist worn accelerometer data from the current K12 of: 5250 (2200) steps/ day and the investigators assume 5% meeting goal at baseline in the control group.
Descriptive statistics will be used to describe the total eligible population, those referred, and those referred who participated in the study; in order to determine program reach. Exploratory Analysis of Important Pre-Existing Factors: Factor analysis will be used to identify importance of factors related to physical activity levels/ activity goal achievement over the 12 month follow-up (Mplus) from participant EHR data collected prior to intervention start. Factor structures of how individual factors contribute to activity outcomes will be explored at each time point. The best factor structure will be determined with Eigenvalues and fit indices (RMSEA, CFI, and TLI). Factor structures at the 2 time points will be compared at three levels to establish measurement invariance: 1) Configural equivalence, number of factors/ pattern of factor-indicator relationships are identical over time; 2) Metric equivalence, factor loadings are equal over time; and 3) Scalar equivalence, means and values are equivalent over time. Finally, the investigators will use descriptive statistics to report presence/absence of data on physical activity levels, cardiometabolic, and patient-centered outcomes in the EHR. The investigators will apply the same regression approaches utilized in Aim 1a to determine differences between randomized groups for EHR reported outcomes.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (care provider, outcomes assessor)
- Number of arms
- 2
- Model description
- Participants will be randomized 1:1 to one of two intervention conditions.
| Arm | Type | Receives |
|---|---|---|
| PAT (Physical activity monitor) | Active comparator | Behavioral: PATParticipants will receive a physical activity tracker and encouragement to increase physical activity. |
| ActiveGOALSv2 | Experimental | Behavioral: ActiveGOALSv2Participants will receive the ActiveGOALS online program with an integrated activity tracker. |
Who may qualify
- Ages
- 40 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- Age 40-70 years of age
- Low physical activity (PA) levels (<150 minutes/week)
- At least one of the following common cardiometabolic risk factors:
- Have access to the internet
- Able to read English at a 6th grade level
Key exclusion criteria (5 listed)
- Have participated in a physical activity intervention program with behavior tracking and goal setting in the past year.
- Told by a physician that they have diabetes (other than previous gestational diabetes) or have received a diagnosis of cardiovascular disease, regardless of when.
- Pregnant or planning a pregnancy in <12 months
- Non-ambulatory or planning a procedure that will lead to not being ambulatory in <12 months.
- Women who become pregnant during the study will be required to get an updated referral form from their primary care provider (PCP) stating that they are able to increase their physical activity without supervision .
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ActiveGOALSv213 weekly self-guided sessions on problem solving and goal setting related to increasing physical activity, and weekly remote coaching support. Once a month support materials sent monthly from months 4-12 of intervention. | Behavioural | ActiveGOALSv2 |
| PATParticipants will receive a physical activity tracker and encouragement to increase activity. | Behavioural | PAT (Physical activity monitor) |
Primary outcome
Change From Baseline in Meeting the Aerobic Activity Goal at 12 Months
Time frame: 12 months versus baseline
Change between 0 and 12 months for y/n meeting the 150 minute/week moderate-vigorous activity goal based on minutes of activity from accelerometer
Change From Baseline in Step Counts at 12 Months
Time frame: 12 months versus baseline
Objectively measured change in step counts between 0 and 12 months using ActiGraph accelerometer
15 secondary outcomes
Sedentary Behavior Minutes Over All Timepoints for 12 Months
Time frame: baseline, 6 and 12 months
Moderate-vigorous Activity Minutes Over All Timepoints for 12 Months
Time frame: baseline, 6 and 12 months
Light Activity Minutes Over All Timepoints for 12 Months
Time frame: baseline, 6 and 12 months
Step Counts Over All Timepoints for 12 Months
Time frame: baseline, 6 and 12 months
Patient Experience
Time frame: measured at 6 and 12 months
Systolic Blood Pressure Over All Timepoints for 12 Months
Time frame: measured at baseline, 6 and 12 months
Body Weight Over All Timepoints for 12 Months
Time frame: measured at baseline, 6 and 12 months
Waist Circumference Over All Timepoints for 12 Months
Time frame: measured at baseline, 6 and 12 months
Fasting Blood Glucose Over All Timepoints for 12 Months
Time frame: measured at baseline, 6 and 12 months
HbA1c Over All Timepoints for 12 Months
Time frame: measured at baseline, 6 and 12 months
LDL Cholesterol Over All Timepoints for 12 Months
Time frame: measured at baseline, 6 and 12 months
HDL Cholesterol Over All Timepoints for 12 Months
Time frame: measured at baseline, 6 and 12 months
Perceived Health Score Over All Timepoints for 12 Months
Time frame: measured at baseline, 6 and 12 months
Insulin Over All Timepoints for 12 Months
Time frame: measured at baseline, 6 and 12 months
Triglycerides Over All Timepoints for 12 Months
Time frame: measured at baseline, 6 and 12 months
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 May 2026.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Physical Inactivity
Active, not recruiting
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
Sedentary Behavior, Physical Inactivity
Not yet recruiting
Individual Variability in Energy Compensation After a 12-Week Supervised Exercise Intervention
Physical Inactivity, Overweight
Not yet recruiting
Effects of Different Amounts of Plyometric Exercise Without Jumping in Physically Inactive Older Adults
Sedentary Behavior / Physical Inactivity, Aging
Active, not recruiting
E-Bike Commuting and Health in Overweight College Students
Obesity &Amp; Overweight, Sedentary Behaviors
Enrolling by invitation
Effects of a School-Based Physical Activity Intervention on 24-Hour Movement Behaviours and Motor Development in Preschool Children - Study Protocol
Physical Inactivity, Sedentariness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Bonny Rockette-Wagner, PhD principal investigator
University of Pittsburgh
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ActiveGOALSv2 and PAT in people with Physical Inactivity and Cardiovascular Risk Factor, run by University of Pittsburgh at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 19 Nov 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change From Baseline in Meeting the Aerobic Activity Goal at 12 Months (time frame: 12 months versus baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.